NCT04793269Active, not recruiting
Characteristics of Long COVID-19 Syndrome
Long COVID Syndrom: Charakterisierung Eines Neuen Krankheitsbildes
Source: ClinicalTrials.gov · Last updated 30 Mar 2025
Brief summary (registry, in English)
Characterization of patients with long COVID syndrome including symptoms, medical history and persistent organ damage.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 4 Mar 2021
- Start date
- 23 Feb 2021
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Christian Clarenbach
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT04793269
What you commit to
- Study type: Observational
- Planned participants: 200
- From 23 Feb 2021 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
Who the study is looking for
- Long COVID syndrome
- age \>= 18 years
- Informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Zurich Coordinator of this site? Confirm its status | Zurich | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.